Last reviewed · How we verify

Codeine with acetaminophen

Children's Hospitals and Clinics of Minnesota · FDA-approved active Small molecule

Codeine is an opioid agonist that binds to mu opioid receptors to reduce pain perception, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects.

Codeine is an opioid agonist that binds to mu opioid receptors to reduce pain perception, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects. Used for Mild to moderate pain in pediatric patients.

At a glance

Generic nameCodeine with acetaminophen
Also known asCapital® with Codeine Suspension, Acetaminophen and Codeine phosphate suspension
SponsorChildren's Hospitals and Clinics of Minnesota
Drug classOpioid analgesic combination
TargetMu opioid receptor (codeine); COX enzymes (acetaminophen)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Codeine is a weak opioid that acts primarily as a mu receptor agonist in the central nervous system, reducing the transmission and perception of pain signals. Acetaminophen works through a separate mechanism by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin production, providing complementary analgesia and fever reduction. The combination provides enhanced pain relief through dual mechanisms of action.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results